CPT® Code 90696

1. Indications

The CPT® Code 90696 is indicated for the administration of a combination vaccine to children aged 4 through 6 years. The specific indications for this vaccine include:

• Diphtheria - A serious bacterial infection that affects the mucous membranes of the throat and nose, leading to severe inflammation and the formation of a thick coating that can obstruct breathing.
• Tetanus - A potentially fatal disease caused by a neurotoxin that leads to painful muscle contractions and spasms.
• Pertussis (Whooping Cough) - An acute respiratory infection characterized by severe coughing fits that can lead to complications, especially in young children.
• Poliomyelitis - A viral infection that can cause paralysis and affects the central nervous system, leading to severe complications.

2. Procedure

The procedure for administering the DTaP-IPV vaccine involves several key steps, which are outlined as follows:

• Step 1: Preparation - Prior to administration, the healthcare provider must ensure that the vaccine is stored correctly and is at the appropriate temperature. The vaccine vial should be inspected for any particulate matter or discoloration, and the provider should gather all necessary supplies, including syringes, alcohol swabs, and gloves.
• Step 2: Patient Assessment - The healthcare provider should assess the child’s medical history, including any previous allergic reactions to vaccines, current health status, and any contraindications to vaccination. This assessment is crucial to ensure the safety and appropriateness of the vaccine for the child.
• Step 3: Administration - The vaccine is administered via intramuscular injection, typically in the anterolateral thigh for younger children. The provider should clean the injection site with an alcohol swab and allow it to dry before inserting the needle at a 90-degree angle to ensure proper delivery of the vaccine into the muscle.
• Step 4: Post-Administration Care - After the injection, the provider should apply gentle pressure to the injection site with a cotton ball or gauze. The child should be monitored for a short period for any immediate adverse reactions, and caregivers should be informed about potential side effects and the importance of follow-up vaccinations.

3. Post-Procedure

Post-procedure care for the DTaP-IPV vaccine includes monitoring the child for any immediate adverse reactions, such as swelling, redness, or pain at the injection site, as well as systemic reactions like fever or irritability. Caregivers should be advised to use appropriate pain relief measures, such as acetaminophen, if necessary. It is also important to inform caregivers about the schedule for follow-up vaccinations and the need for additional doses to ensure full immunity against the diseases covered by the vaccine. Documentation of the vaccine administration, including the date, lot number, and site of injection, should be recorded in the child's medical record for future reference.